What Is the Primary Driver of Preoperative Vancomycin Use? It's Not Methicillin-resistant Staphylococcus aureus-or Allergy.

Autor:	Strymish JM; Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., O' Brien W; Harvard Medical School, Boston, Massachusetts, USA., Itani K; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.; Boston University School of Medicine, Boston, Massachusetts, USA., Gupta K; Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.; Boston University School of Medicine, Boston, Massachusetts, USA.; Veterans Affairs Center for Healthcare Organization and Implementation Research, Boston, Massachusetts, USA., Branch-Elliman W; Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Veterans Affairs Center for Healthcare Organization and Implementation Research, Boston, Massachusetts, USA.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 17; Vol. 71 (10), pp. 2732-2735.
DOI:	10.1093/cid/ciaa475
Abstrakt:	Factors driving vancomycin surgical prophylaxis are poorly understood. In a national Veterans Affairs cohort with manually validated data, surgical specialty (cardiac, orthopedics) and perception of high facility methicillin-resistant Staphylococcus aureus (MRSA) prevalence-not MRSA colonization-were the primary drivers of prescribing. A β-lactam allergy was the second most common reason. These data may inform perioperative stewardship. (Published by Oxford University Press for the Infectious Diseases Society of America 2020.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu